Novanta (NASDAQ:NOVT) Issues Quarterly Earnings Results, Beats Estimates By $0.06 EPS

Novanta (NASDAQ:NOVT) released its earnings results on Wednesday. The technology company reported $0.89 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.83 by $0.06, FiscalAI reports. Novanta had a net margin of 5.35% and a return on equity of 12.06%. The company had revenue of $265.81 million for the quarter, compared to analyst estimates of $262.30 million. During the same period in the prior year, the firm earned $0.76 EPS. The firm’s quarterly revenue was up 10.3% on a year-over-year basis. Novanta updated its FY 2026 guidance to 3.680-3.740 EPS and its Q3 2026 guidance to 0.950-1.000 EPS.

Novanta Stock Down 4.0%

NOVT opened at $153.12 on Thursday. The company has a debt-to-equity ratio of 0.15, a current ratio of 3.56 and a quick ratio of 2.69. The stock has a market capitalization of $5.78 billion, a price-to-earnings ratio of 110.96 and a beta of 1.68. The business has a 50-day moving average of $153.85 and a two-hundred day moving average of $141.21. Novanta has a 12 month low of $98.27 and a 12 month high of $171.85.

More Novanta News

Here are the key news stories impacting Novanta this week:

• Positive Sentiment: Novanta reported adjusted earnings of $0.89 per share, above the $0.83 analyst consensus and up from $0.76 a year earlier. Revenue increased 10.3% year over year to $265.8 million, exceeding estimates of $262.3 million. Novanta Q2 Earnings Snapshot
• Positive Sentiment: Management issued third-quarter adjusted EPS guidance of $0.95 to $1.00, above the $0.94 consensus, and revenue guidance of approximately $300 million to $304 million, well above the $263.1 million estimate. Novanta Announces Financial Results for the Second Quarter 2026
• Positive Sentiment: Full-year 2026 adjusted EPS guidance was raised or reaffirmed at $3.68 to $3.74, ahead of the $3.59 consensus. The results point to continued growth and stronger near-term operating momentum. Novanta Tops Q2 Earnings and Revenue Estimates
• Neutral Sentiment: The company’s earnings release was the main catalyst, while pre-earnings coverage focused on whether Novanta could meet elevated expectations. Novanta Reports Earnings Tomorrow
• Negative Sentiment: Despite the strong report, NOVT traded lower. Its valuation—approximately 111 times earnings—may have encouraged profit-taking or disappointed investors seeking an even larger upside surprise. The available reports do not identify a specific operational setback.

Wall Street Analysts Forecast Growth

NOVT has been the subject of a number of analyst reports. Robert W. Baird set a $180.00 price objective on shares of Novanta in a research report on Tuesday, June 9th. Weiss Ratings restated a “hold (c-)” rating on shares of Novanta in a research report on Wednesday, July 15th. Finally, Wall Street Zen cut shares of Novanta from a “buy” rating to a “hold” rating in a research note on Saturday, August 1st. One analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $180.00.

Insider Activity at Novanta

In other news, CEO Matthijs Glastra sold 7,500 shares of the stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $150.43, for a total transaction of $1,128,225.00. Following the transaction, the chief executive officer directly owned 42,761 shares in the company, valued at $6,432,537.23. This represents a 14.92% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.20% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Novanta

Institutional investors have recently bought and sold shares of the stock. Danske Bank A S purchased a new position in Novanta during the third quarter worth approximately $40,000. Van ECK Associates Corp grew its stake in shares of Novanta by 17.2% during the 3rd quarter. Van ECK Associates Corp now owns 1,627 shares of the technology company’s stock valued at $163,000 after buying an additional 239 shares during the period. O Shaughnessy Asset Management LLC acquired a new stake in shares of Novanta during the 4th quarter worth $219,000. Boothbay Fund Management LLC purchased a new position in shares of Novanta in the 3rd quarter worth $261,000. Finally, EntryPoint Capital LLC purchased a new position in shares of Novanta in the 4th quarter worth $261,000. 98.35% of the stock is currently owned by hedge funds and other institutional investors.

About Novanta

Novanta, Inc (NASDAQ: NOVT) is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta’s product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.

Novanta’s Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.